abstracts

0

Page précédente

Abstracts Strasbourg 2004

Type présentation Jour(s) N° Session Auteurs Titre Adresses
Poster 26-28   24  P094 H Allain (1); H Le Louet (2); D Bentue-Ferrer (1); A Delgado (3); L Guesnier (3); Is the DHE – Triptans contraindication still justified ? 
Abstract complet
(1) Laboratoire de Pharmacologie, Faculté de Médecine, Rennes; (2) Centre de Pharmacovigilance, CHU Henri Mondor, Créteil; (3) Schwarz Pharma, Laboratoires, Boulogne;
Poster 26-28   24  P095 C Brefel-Courbon (1); P Payoux (2); C Thalamas (3); O Blin (4); F Durif (5); JP Azulay (6); F Tison (7); C Geny (8); JL Montastruc (1); O Rascol (1); Levodopa effect on cortical motor activity in Cerebellar Multiple System Atrophy: a PET Study 
Abstract complet
(1) Service de Pharmacologie, Faculté de médecine, Toulouse; (2) INSERM U455, CHU de Toulouse, Toulouse; (3) Centre d’Investigation Clinique, CHU de Toulouse, Toulouse; (4) Service de Pharmacologie, CHU, Marseille; (5) Service de Neurologie, CHU, Clermont Ferrand; (6) Service de Neurologie, CHU, Marseille; (7) Service de Neurologie, CHU de Bordeaux, Bordeaux; (8) Service de Neurologie, CHR, Pau;
Poster 26-28   24  P096 G Pickering (1); A Eschalier (1); C Dubray (1); Inhibition of the analgesic effect of acetaminophen by a 5-HT3 antagonist in healthy volunteers 
Abstract complet
(1) Centre de Pharmacologie Clinique, Faculté de Médecine, Clermont Ferrand;
Poster 26-28   24  P097 G Louin (1); C Marchand-Verrecchia (1); M Plotkine (1); M Jafarian-Tehrani (1); 1400W, a potent selective inducible NOS inhibitor, improves functional outcome following traumatic brain injury in rats 
Abstract complet
(1) Laboratoire de Pharmacologie UPRES EA2510, Université René Descartes, Paris;
Poster 26-28   24  P098 F Chenu (1); C Przybylski (2); R Hen (3); AM Gardier (2); M Bourin (1); 5-HT1B heteroreceptors: a new potent target for antidepressant drugs ? 
Abstract complet
(1) EA 3256, Faculté de Médecine, Nantes; (2) EA 3544, Faculté de Pharmacie, Châtenay-Malabry; (3) Center for Neurobiology and Behavior, New-York, USA;
Poster 26-28   24  P099 V Lelong Boulouard (1); F Moreaux (2); T Quentin (1); D Debruyne (1); M Boulouard (2); A Coquerel (1); Interaction between buprenorphine and dipotassium clorazepate in memory processes in mice 
Abstract complet
(1) Service de Pharmacologie, Faculté de Médecine – CHU Caen, Caen; (2) UPRES EA 2126, UFR des Sciences Pharmaceutiques, Caen;
Poster 26-28   24  P100 B Aubel (1); V Kayser (1); A Farré (2); M Hamon (1); S Bourgoin (1); Evidence for adenosine- and serotonin-mediated antihyperalgesic effect of cizolirtine in rats suffering from diabetic neuropathy 
Abstract complet
(1) INSERM U288, Faculté de Médecine Pitié-Salpêtrière, Paris; (2) Laboratorios Dr Esteve S.A., Av. Mare de Déu de Montserrat, 221, Barcelona, Spain;
Poster 26-28   24  P101 R Laguzzi (1); MA Comet (1); M Hamon (1); C Sévoz-Couche (1); Substance P in the nucleus tractus solitarius is involved in the inhibition of baroreflex bradycardia during the defense reaction 
Abstract complet
(1) INSERM U288, Faculté de Médecine Pitié-Salpêtrière, Paris;
Poster 26-28   24  P102 V Lelong Boulouard (1); T Freret (2); F Dauphin (2); M Boulouard (2); Effect of a combined treatment with a cholinesterase inhibitor (galanthamine) and a 5-HT4 receptor agonist (RS 67333) on long term memory performances in the mouse 
Abstract complet
(1) Service de Pharmacologie, Faculté de Médecine – CHU Caen, Caen; (2) UPRES EA 2126, UFR des Sciences Pharmaceutiques, Caen;
Poster 26-28   24  P103 T Freret (1); S Valable (2); L Chazalviel (2); ET Mackenzie (2); E Petit (2); M Bernaudin (2); P Schumann-Bard (2); M Boulouard (1); Effects of deferoxamine on functional recovery after focal cerebral ischemia in the rat 
Abstract complet
(1) CERMN EA2126, Université de Caen, Caen; (2) CNRS UMR6185 – Cycéron, Université de Caen, Caen;

Page précédente